Trial Profile
Efficacy and safety of ustekinumab in patients with inflammatory bowel disease:A real world study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Jan 2018
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary) ; Ustekinumab (Primary)
- Indications Crohn's disease; Inflammatory bowel diseases
- Focus Adverse reactions; Therapeutic Use
- 18 Jan 2018 New trial record